How Institutional Funds Moved on QTTB

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
Boxer Capital Management, LLC Boxer Capital Management, LLC opened a new position worth $40,122,209. 2026-06-30
ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC increased this position by 264% ($14,464,177 -> $52,590,554). 2026-06-30
BVF INC/IL BVF INC/IL opened a new position worth $29,939,000. 2026-06-30
RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P. opened a new position worth $29,715,502. 2026-06-30
Atlas Venture Life Science Advisors, LLC Atlas Venture Life Science Advisors, LLC increased this position by 158% ($13,431,321 -> $34,615,930). 2026-06-30
Point72 Asset Management, L.P. Point72 Asset Management, L.P. opened a new position worth $14,949,065. 2026-06-30
RENAISSANCE TECHNOLOGIES LLC RENAISSANCE TECHNOLOGIES LLC increased this position by 72% ($1,328,394 -> $2,288,104). 2026-06-30
Logos Global Management LP Logos Global Management LP opened a new position worth $10,192,000. 2026-06-30

Which Funds Hold QTTB

Largest reported positions as of 2026-06-30.

FundValueShares
ORBIMED ADVISORS LLC $52,590,554 4,127,987
Boxer Capital Management, LLC $40,122,209 3,149,310
Atlas Venture Life Science Advisors, LLC $34,615,930 2,717,106
BVF INC/IL $29,939,000 2,350,000
RA CAPITAL MANAGEMENT, L.P. $29,715,502 2,332,457
Point72 Asset Management, L.P. $14,949,065 1,173,396
Opaleye Management Inc. $11,860,940 931,000
Logos Global Management LP $10,192,000 800,000
SummitTX Capital, L.P. $9,348,281 733,774
VANGUARD CAPITAL MANAGEMENT LLC $6,609,550 518,803

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Sanofi’s 13F Portfolio Moves, Tracked Quarter by Quarter

Table-style overview of Sanofi's 13F portfolio changes for the quarter ending June 30, 2026, showing new positions in AGMB, ODTX, and TRAX, increases in MGTX, NVAX, INBX, MPLT, ANAB, and QTTB, a reduction in IMRX, and an exit from Eledon.

This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more